Executive Search Firm Toft Group Places Felecia Manning, CPA as Associate Director, Market Access, Pricing & Reimbursement with Theravance BioPharma, Inc. in South San Francisco, CA

Toft Group Executive Search has placed Ms. Felecia Manning as the Associate Director of Market Access, Pricing & Reimbursement with Theravance BioPharma in South San Francisco, California. Ms. Manning was most recently with Deloitte as Manager of Risk & Financial Advisory. She came to Deloitte from Gilead Sciences where she was the Senior Manager, Government Pricing & Contracting. Earlier in her industry career, Ms. Manning held financial roles with Merz North America, Inc., and APEX Analytix, Inc.

Ms. Manning holds a M.S. in Accountancy and a B.S. in Business Administration from Wake Forest University of North Carolina. She is a Certified Public Accountant for both North Carolina and California.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Theravance BioPharma, Inc.

Theravance Biopharma, Inc. (“Theravance Biopharma”) is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness.

Executive Search Firm Toft Group Places Diane Ingolia as Senior Director, Regulatory Affairs with Ascendis Pharma in Palo Alto, CA

Toft Group Executive Search has placed Ms. Diane Ingolia, JD, as Senior Director of Regulatory Affairs with Ascendis Pharma in Palo Alto, California. Ms. Ingolia comes to Ascendis with many years of experience in growing biotechnology companies with her expertise in regulatory affairs. She was most recently the Executive Director of Global Regulatory Affairs with Dermira, Inc. Previously, Ms. Ingolia held leadership positions in regulatory affairs with Affymax, Inc. and Genitope Corporation.

Ms. Ingolia holds a J.D. from Santa Clara University School of Law, a PhD in Biochemistry from Baylor College of Medicine, and a B.S. in Medical Technology from the University of New Orleans.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Ascendis Pharma

Ascendis Pharma is applying its innovative platform technology to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon™ technology to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three wholly-owned, independent rare disease endocrinology product candidates in clinical development. Additionally, Ascendis Pharma has multi-product collaborations with Sanofi in diabetes and Genentech in the field of ophthalmology and continues to expand into additional therapeutic areas for both internal and external development. Ascendis is headquartered in Copenhagen, Denmark, with offices in Heidelberg, Germany and Palo Alto, California.

Toft Group Executive Search Places Charles Ziegler, MBA as Chief Financial Officer with MedLabs Diagnostics in Cedar Knolls, NJ

Executive search firm Toft Group has successfully placed Mr. Charles Ziegler, MBA as Chief Financial Officer with MedLabs Diagnostics in Cedar Knolls, New Jersey. MedLabs Diagnostics is the longest-serving and one of the most advanced diagnostic testing laboratories in the northeastern United States.

Mr. Ziegler has over thirty years of financial leadership within the pharmaceutical, diagnostics and medical device industries. He most recently served as Vice President of Finance for Abbott Rapid Diagnostics, North America. In that role, he led the finance functions for five business units in eight locations and three countries. Notably, Mr. Ziegler developed strategic financial operating plan projections for five North America business units and served on team that successfully integrated eleven acquisitions.

Previously, Mr. Ziegler served Alere as their Vice President, Finance and Operations. Prior to Alere, Mr. Ziegler held progressive financial roles with MedPointe Pharmaceuticals (a private equity owned medical diagnostics company), most recently as Corporate Controller.

Mr. Ziegler holds an MBA and a BS in Accounting from Rider University in Lawrenceville, New Jersey.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About MedLabs Diagnostics

MedLabs Diagnostics is one of the oldest independent reference laboratories in the United States with headquarters in Cedar Knolls, NJ. The Company provides a large, comprehensive menu of laboratory developed, esoteric, STAT and routine tests, which has been created through sixty-seven years of providing exceptional service and industry-leading turnaround time. The team of professionals at MedLabs, with the help of highly innovative diagnostic tests and proprietary software, enable medical providers to tackle today’s healthcare challenges and make a difference in the lives of millions of patients.

 

 

Executive search firm Toft Group places John Norkett as Vice President of Managed Care, East with LabCorp in Burlington, NC

Toft Group Executive Search has placed Mr. John Norkett as Vice President of Managed Care, East with LabCorp in Burlington, North Carolina. Mr. Norkett was most recently Senior Vice President of Sales and Client Services for Inform Diagnostics. Previously, Mr. Norkett was VP of Reimbursement for Progenity, and Sr. VP of Managed Care and Reimbursement for Miraca Life Sciences. Mr. Norkett held key leadership roles with Laboratory Corporation of America as an Area Director of Business Development He also served as Regional Sales Director of Health Plans at Quest Diagnostics.

Mr. Norkett holds a B.S. in Finance & Economics from DePaul University in Chicago.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About LabCorp

LabCorp, an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.

Executive search firm Toft Group places Carmine Stengone as CEO of Pipeline Therapeutics, San Diego, CA

Toft Group Executive Search has placed Mr. Carmine Stengone as Chief Executive Officer with Pipeline Therapeutics in San Diego, California. Mr. Stengone recently served as President and CEO of Avelas Biosciences. Prior to that he was Senior Vice President, Business Development for COI Pharmaceuticals. Mr. Stengone was also Vice President of Corporate Development for Afraxis Holdings, Senior Director of BD with Phenomix Corporation, and has held positions with Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development.

Mr. Stengone holds an MBA from the Johnson Graduate School of Management at Cornell University, an M.S. in Organic Chemistry from Duke University, and a B.S. in Chemistry from Wake Forest University.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles. Toft Group has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Pipeline Therapeutics

Pipeline Therapeutics is using innovative research strategies to develop novel drugs for the treatment of MS and other demyelinated diseases by enhancing the functional restoration of the affected nerves.

 

Executive search firm Toft Group places Daniela Do Anjos Hanova as Vice President, Human Resources with Exact Sciences in Madison, WI

Toft Group Executive Search has placed Ms. Daniela Dos Anjos Hanova as Vice President of Human Resources for Exact Sciences in Madison, Wisconsin. Ms. Hanova was most recently with AstraZeneca as Global HR Director. Previous to AstraZeneca, Ms. Hanova worked for Abbott as Division HR Director. Earlier in her industry career, she served with Solvay Pharmaceuticals (now Abbott) as Zone HR Director and PriceWaterhouseCooper as Human Resources Services Manager.

Ms. Hanova holds a MA in English and Russian Languages and Literature from Comenius University, Slovakia.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Exact Sciences

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer.

 

 

Executive search firm Toft Group places Nico Pannacciulli, MD, PhD, as Executive Medical Director, Clinical Development with Intercept Pharmaceuticals in San Diego, CA

Toft Group Executive Search has placed Nico Pannacciulli, MD, PhD, as Executive Medical Director, Clinical Development with Intercept Pharmaceuticals in San Diego, California.  Dr. Pannacciulli previously worked with Amgen as Clinical Research Medical Director, Bone Therapeutic Area and was later promoted to Global Development Leader. Before working with Amgen, Dr. Pannacciulli was the Director, Cardiovascular Clinical Research at Gilead Sciences. He also worked with Bristol-Myers Squibb as their Medical Director, CV/Metabolic. Earlier in his industry career, Dr. Pannacciulli was the Associate Director, Clinical Development at Amylin.

Dr. Pannacciulli received his MD from the University of Bari, Italy and his PhD in Endocrine and Metabolic Sciences from the University of Naples, Italy.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Intercept Pharmaceuticals

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

 

Executive search firm Toft Group places Paul Shin as Vice President, Clinical Operations with Intercept Pharmaceuticals in San Diego, CA

Toft Group Executive Search has placed Paul Shin as Vice President of Clinical Operations for Intercept Pharmaceuticals in San Diego, California. Mr. Shin was most recently Global Head of R&D Operations at Nestle Health Science. Previously, he worked with Avanir Pharmaceuticals as Vice President, Research & Development Operations, Sr. Director, Clinical Operations & Pharmacovigilance at Spectrum Pharmaceuticals, and Director, Clinical Operations & Medical Affairs at Prometheus Therapeutics & Diagnostics. Earlier in his industry career, Mr. Shin supported clinical operations for Valeant Pharmaceuticals and MDS Pharma Services.

Mr. Shin holds a B.S. in Psychobiology from the University of California, Riverside.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Intercept Pharmaceuticals

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.

 

Executive search firm Toft Group places R. Eric Gerber as Senior Vice President, Strategy and Corporate Development for Agilent Technologies, Inc. in Santa Clara, CA

 

Toft Group Executive Search has placed R. Eric Gerber as Senior Vice President, Strategy and Corporate Development with Agilent Technologies, Inc. in Santa Clara, California. Mr. Gerber was previously Vice President of Business Development at SCIEX. Before joining SCIEX, he was Senior Director of Business Development for Dionex Corporation where he headed corporate BD and strategic planning. Earlier in his career, Eric was responsible for technology incubation at Applied Biosystems and worked as a Product Manager in Varian’s chromatography division. Eric started his career as a synthetic organic chemist at Shaman Pharmaceuticals in South San Francisco.

Mr. Gerber holds a B.A. in Organic Chemistry from Reed College, Portland, Oregon.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Agilent Technologies, Inc.

Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers’ most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 14,800 people worldwide.

Executive search firm Toft Group places Deanna Hunt as Senior Director, Regulatory Affairs with HealthTell, Inc. in San Ramon, CA.

Toft Group Executive Search has placed Ms. Deanna Hunt as Senior Director, Regulatory Affairs with HealthTell, Inc. in San Ramon, California. Prior to joining HealthTell, Ms. Hunt was Director of Regulatory Affairs for Amnio Technology, LLC. Ms. Hunt has held joint QA & RA leadership positions where she has provided quality & regulatory oversight for a multitude of medical technologies.  She was previously Director of QA and Regulatory Affairs with Plasmology4, and she worked as a Quality Systems Manager with CIRTEC Medical Systems.

Ms. Hunt holds a B.S. in Psychology from the College of Charleston.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About HealthTell, Inc.

HealthTell, Inc., headquartered in San Ramon, CA, is pioneering the field of immunomics. The company is developing next generation immune profiling assays that broadly characterize the immune system, serving as a platform technology for the biopharmaceutical, search and clinical communities. The technology uses a proprietary immune profiling technology to analyze the immune system’s response against disease – with unprecedented depth and specificity. With applications in drug target discovery, monoclonal antibody characterization, and disease monitoring and therapeutic response, HealthTell will shed new light on important diseases such as autoimmune, cancer, CNS, and infectious disease. HealthTell operates a state-of-the-art high throughput centralized laboratory in San Ramon, CA that supports clients in biopharmaceuticals and research collaborators.